This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riviere, Y Articles by Oldstone, M B Search for Related Content PubMed PubMed Citation Articles by Riviere, Y Articles by Oldstone, M B

 Previous Article  |  Next Article 

J Virol. 1986 August; 59(2): 363-368

Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis.

ABSTRACT

Reassortant viruses of different strains of lymphocytic choriomeningitis viruses cause lethal disease after inoculation into neonatal BALB/c WEHI mice, but, in contrast, parental strains or reciprocal reassortants do not cause lethal disease. The disease is characterized by inhibition of growth and death. The pathogenic mechanism is the induction of interferon combined with higher virus titers and subsequent liver necrosis. The generation of lethal reassortants from nonlethal parent viruses likely has implications for understanding the outbreaks of unanticipated virulent disease within a viral family.

This article has been cited by other articles:

• Lukashevich, I. S., Patterson, J., Carrion, R., Moshkoff, D., Ticer, A., Zapata, J., Brasky, K., Geiger, R., Hubbard, G. B., Bryant, J., Salvato, M. S. (2005). A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses. J. Virol. 79: 13934-13942 [Abstract] [Full Text]  
• Pariente, N., Sierra, S., Lowenstein, P. R., Domingo, E. (2001). Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors. J. Virol. 75: 9723-9730 [Abstract] [Full Text]  
• Sewell, A. K., Price, D. A., Oxenius, A., Kelleher, A. D., Phillips, R. E. (2000). Cytotoxic T Lymphocyte Responses to Human Immunodeficiency Virus: Control and Escape. Stem Cells 18: 230-244 [Abstract] [Full Text]  
• von Herrath, M. G., Coon, B., Lewicki, H., Mazarguil, H., Gairin, J. E., Oldstone, M. B. A. (1998). In Vivo Treatment with a MHC Class I-Restricted Blocking Peptide Can Prevent Virus-Induced Autoimmune Diabetes. J. Immunol. 161: 5087-5096 [Abstract] [Full Text]